Corin Tillier

The Netherlands Cancer Institute

Papers

1

Total Citations

36

H-Index

1

About

Corin Tillier is a leading researcher in urological oncology, with a primary focus on optimizing quality of life (QoL) outcomes for men diagnosed with low-risk prostate cancer. Her most impactful work, a comparative retrospective study published in 2013, rigorously investigated QoL following three distinct treatment modalities: brachytherapy, robot-assisted laparoscopic prostatectomy (RALP), and active surveillance (AS). By employing validated questionnaires on a prospective database, Tillier provided critical, patient-centered evidence that helps guide shared decision-making. This landmark study, which has garnered 36 citations, demonstrated her commitment to moving beyond purely clinical endpoints to understand the real-world, lived experiences of patients. Her research is instrumental in demonstrating that for low-risk disease, treatment choice has profound and differential impacts on urinary, sexual, and bowel function. Tillier’s work empowers clinicians and patients alike, ensuring that the conversation around prostate cancer management is as much about preserving quality of life as it is about oncological control.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Quality of Life in Patients with Low-Risk Prostate Cancer. A Comparative Retrospective Study: Brachytherapy Versus Robot-Assisted Laparoscopic Prostatectomy Versus Active Surveillance
36 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago